These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18354860)

  • 21. Trans-telephonic monitoring of continuous haemodynamic measurements in heart failure patients.
    Kjellström B; Igel D; Abraham J; Bennett T; Bourge R
    J Telemed Telecare; 2005; 11(5):240-4. PubMed ID: 16035966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.
    Sweeney MO; Ellenbogen KA; Miller EH; Sherfesee L; Sheldon T; Whellan D
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1295-8. PubMed ID: 17081208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct left atrial pressure monitoring in ambulatory heart failure patients: initial experience with a new permanent implantable device.
    Ritzema J; Melton IC; Richards AM; Crozier IG; Frampton C; Doughty RN; Whiting J; Kar S; Eigler N; Krum H; Abraham WT; Troughton RW
    Circulation; 2007 Dec; 116(25):2952-9. PubMed ID: 18056531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How well are chronic heart failure patients being managed?
    Fonarow GC
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Device therapy in advanced heart failure: what to put in and what to turn off: remote telemonitoring and implantable hemodynamic devices for advanced heart failure monitoring in the ambulatory setting and the evolving role of cardiac resynchronization therapy.
    Smith SA; Abraham WT
    Congest Heart Fail; 2011; 17(5):220-6. PubMed ID: 21906246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized clinical trial of the clinical effects of enhanced heart failure monitoring using a computer-based telephonic monitoring system in older minorities and women.
    Soran OZ; Piña IL; Lamas GA; Kelsey SF; Selzer F; Pilotte J; Lave JR; Feldman AM
    J Card Fail; 2008 Nov; 14(9):711-7. PubMed ID: 18995174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension.
    Frantz RP; Benza RL; Kjellström B; Bourge RC; Barst RJ; Bennett TD; McGoon MD
    J Heart Lung Transplant; 2008 Jul; 27(7):780-8. PubMed ID: 18582809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remote Active Monitoring in Patients with Heart Failure (RAPID-RF): design and rationale.
    Saxon LA; Boehmer JP; Neuman S; Mullin CM
    J Card Fail; 2007 May; 13(4):241-6. PubMed ID: 17517341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proactive monitoring: implications of implantable devices for future heart failure management.
    Daleiden-Burns A; Stiles P
    Crit Care Nurs Q; 2007; 30(4):321-8. PubMed ID: 17873568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale and design of a prospective trial to assess the sensitivity and positive predictive value of implantable intrathoracic impedance monitoring in the prediction of heart failure hospitalizations: the SENSE-HF study.
    Cowie MR; Conraads V; Tavazzi L; Yu CM;
    J Card Fail; 2009 Jun; 15(5):394-400. PubMed ID: 19477399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Learning the points of COMPASS-HF: assessing implantable hemodynamic monitoring in heart failure patients.
    Teerlink JR
    J Am Coll Cardiol; 2008 Mar; 51(11):1080-2. PubMed ID: 18342225
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of left ventricular lead location on outcomes in the COMPANION study.
    Saxon LA; Olshansky B; Volosin K; Steinberg JS; Lee BK; Tomassoni G; Guarnieri T; Rao A; Yong P; Galle E; Leigh J; Ecklund F; Bristow MR
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):764-8. PubMed ID: 19298563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic changes in right ventricular pressures during haemodialysis recorded with an implantable haemodynamic monitor.
    Braunschweig F; Kjellström B; Söderhäll M; Clyne N; Linde C
    Nephrol Dial Transplant; 2006 Jan; 21(1):176-83. PubMed ID: 16144845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart failure: is there a role for angiotensin II receptor blockers?
    Boucher M; Ma J
    Issues Emerg Health Technol; 2002 Sep; (38):1-4. PubMed ID: 12243202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating device monitoring into the infrastructure and workflow of routine practice.
    Adamson PB
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S42-6. PubMed ID: 16955059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting on the CardioMEMS Champion Heart Failure Monitoring System.
    Loh JP; Barbash IM; Waksman R
    J Am Coll Cardiol; 2013 Apr; 61(15):1571-6. PubMed ID: 23352783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TEACH: Trial of Education And Compliance in Heart dysfunction chronic disease and heart failure (HF) as an increasing problem.
    Gwadry-Sridhar F; Guyatt G; O'Brien B; Arnold JM; Walter S; Vingilis E; MacKeigan L
    Contemp Clin Trials; 2008 Nov; 29(6):905-18. PubMed ID: 18703166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.
    Udelson JE; McGrew FA; Flores E; Ibrahim H; Katz S; Koshkarian G; O'Brien T; Kronenberg MW; Zimmer C; Orlandi C; Konstam MA
    J Am Coll Cardiol; 2007 Jun; 49(22):2151-9. PubMed ID: 17543634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure.
    Masoudi FA; Havranek EP; Wolfe P; Gross CP; Rathore SS; Steiner JF; Ordin DL; Krumholz HM
    Am Heart J; 2003 Aug; 146(2):250-7. PubMed ID: 12891192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Usefulness of home monitoring in patients with implantable cardioverter-defibrillators].
    Pedrinazzi C; Inama G; Durin O; Munoz CV; De Simoni S; Fagandini F; Savazza R; Ablondi L
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):47S-51S. PubMed ID: 19195306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.